Search for: "MERCK " Results 621 - 640 of 3,309
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Feb 2017, 12:03 pm by Eric Turkewitz
From the Merck Manual, in an overview on the subject: All people are entitled to confidentiality unless they give permission for disclosure or they clearly can no longer express a preference (for example, if they are severely confused or comatose). [read post]
2 Feb 2017, 6:00 am by Bottar Leone, PLLC
The device, manufactured by Merck, was supposed to inhibit ovulation for at least three years. [read post]
25 Jan 2017, 10:48 pm
Like AIPPI's final talk of 2016, the AmeriKat is alsobristling - but instead of patent law issues, she is bristling having spotted someone wearing socks with sandalsRight before the Christmas holidays, the UK Group of AIPPI held the annual session devoted to reviewing the year's patent cases. [read post]
23 Jan 2017, 2:59 pm by Kevin LaCroix
(The two 2016 billion dollar settlements arose in the Household International Case and the Merck case.) [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Anticipation/Obviousness: Merck & Cie, et al. v. [read post]
13 Jan 2017, 9:24 am
  A declaration in these terms is described as an Arrow declaration, due to the form of relief sought in Arrow Generics Limited v Merck & Co. [read post]
6 Jan 2017, 2:01 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in passing off… [read post]
5 Jan 2017, 2:15 am by Steve Brachmann
On Thursday, December 15th, a subsidiary of Kenilworth, NJ-based pharmaceutical developer Merck & Co. [read post]
30 Dec 2016, 2:58 pm
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in passing off… [read post]
22 Dec 2016, 8:35 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in passing off… [read post]
19 Dec 2016, 1:45 pm by Anthony McCain
Lauren Anderson & Ryan Cagle: An Examiner’s Tips For Speedier Patent Prosecution Jeff John Roberts: Supreme Court To Mess With Texas Over Patents Florian Mueller: Apple CFO: “What The [EU] Commission Is Doing Here Is A Disgrace For European Citizens” Juliet Preston: Gilead To Pay Merck $2.54B In Largest-Ever Patent Infringement Case Joseph Herndon: iVenture Card Traveler Ltd v. [read post]
16 Dec 2016, 7:19 am by Juliet Preston, MedCity News
A federal jury has awarded $2.54 billion in royalties to Merck, ruling against Gilead in a monumental patent infringement case involving two blockbuster hepatitis C drugs. [read post]
16 Dec 2016, 4:44 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in passing off… [read post]
15 Dec 2016, 3:08 pm by Dennis Crouch
Merck’s sub Idenix was just awarded $2.54 billion for Gilead’s infringement of its Hep-C treatment patents. [read post]
9 Dec 2016, 1:00 pm
Eleonora Rosati discusses the VAT Directive comprising the equal treatment for both printed and electronic publications and its implications on digital exhaustion matters.Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co LimitedGuest Kat Eibhlin Vardy recaps Merck Sharp and Dohme Limited v Shionongi & Co Limited, [2016] EWHC 2989 (Pat), involving the alleged infringement of Shionogi’s European Patent, entitled “Antiviral… [read post]
2 Dec 2016, 3:30 am
  The patent was opposed by Merck at the EPO, but maintained in an amended form. [read post]
24 Nov 2016, 8:23 pm by Kate Howard
The petition of the day is: Merck & Cie v. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
The Merck petition is focused on pre-AIA patents. [read post]